CCM
GWPH

CAAS Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

CAAS Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,234
Closed -$274K – 659
2020
Q2 		$274K Buy
+2,234
New +$253K 0.01% 357

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CAAS Capital Management's GWPH Position: Q3 2020 in Review

CAAS Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 2,234 shares — an estimated $274K sold.

CAAS Capital Management first reported a position in GWPH in Q2 2020 and held it in 1 quarter. The position peaked at $274K in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • CAAS Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • CAAS Capital Management sold 2,234 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $274K.
  • CAAS Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2020 and held it in 1 quarter.
  • CAAS Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $274K in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on CAAS Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.